Medical Research

Oral Precision Therapies Redefine Achondroplasia Treatment
Clinical & Pharma Oral Precision Therapies Redefine Achondroplasia Treatment

The fundamental biology of achondroplasia, which is the primary cause of disproportionate short stature, revolves around a persistent gain-of-function mutation in the FGFR3 gene that effectively halts the conversion of cartilage into bone. This condition affects approximately one in every 25,000

Wearable Tech and AI Transform Cardiovascular Care
Tech & Innovation Wearable Tech and AI Transform Cardiovascular Care

A landmark international partnership between the National Heart and Lung Institute at Imperial College London and Stanford University is fundamentally altering the landscape of cardiovascular medicine through digital innovation. By evolving the "My Heart Counts" application from a simple wellness

Why Are Spinal Cord Stimulators Facing a Wave of Lawsuits?
Clinical & Pharma Why Are Spinal Cord Stimulators Facing a Wave of Lawsuits?

A medical device intended to alleviate chronic suffering can quickly transform into a source of catastrophic injury when technical malfunctions occur within the delicate confines of the human spinal column. The landscape of American medical device litigation has recently seen a tectonic shift with

Jazz and AbCellera Sign $4 Billion Oncology Partnership
Clinical & Pharma Jazz and AbCellera Sign $4 Billion Oncology Partnership

The relentless pursuit of innovative cancer treatments has reached a defining moment as the pharmaceutical sector increasingly turns toward complex, multispecific antibody platforms to solve the riddle of treatment-resistant tumors. This strategic evolution is perfectly exemplified by the recent

AI-Generated Citation Fraud Surges in Biomedical Research
Tech & Innovation AI-Generated Citation Fraud Surges in Biomedical Research

The integrity of modern medical knowledge is currently facing an unprecedented crisis as the foundation of peer-reviewed literature becomes increasingly saturated with fabricated data and non-existent citations. Recent reports published in The Lancet have uncovered a disturbing trend where forged

How Can Spatial Biology De-Risk Drug Discovery?
Clinical & Pharma How Can Spatial Biology De-Risk Drug Discovery?

The multi-billion dollar failure rate of therapeutic candidates in phase three clinical trials has forced the pharmaceutical industry to reconsider its reliance on bulk tissue analysis in favor of high-resolution spatial insights. For decades, the standard approach involved next-generation

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later